COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

August 28, 2020 00:25:38
Episode Cover

Ketamine in the Critically Ill

Ketamine is a well-known anesthetic used commonly in the ED for RSI and procedural sedation.  In this podcast, we review the use of ketamine...

Listen

Episode 0

April 28, 2023 00:27:21
Episode Cover

Should We Add Fludrocortisone to Hydrocortisone for Septic Shock?

The use of steroids in patients with sepsis and septic shock has been controversial for decades. At present, the Surviving Sepsis Campaign recommends the...

Listen

Episode 0

January 06, 2020 00:34:59
Episode Cover

A Year in Review: Key Articles from the 2019 Critical Care Literature

A plethora of literature was published during the course of 2019.  In this podcast, we review several key articles published in the 2019 critical...

Listen